甲状旁腺激素调控牙周组织改建的研究进展

doi:10.7518/gjkq.2017.04.019

摘要/Abstract

摘要： 甲状旁腺激素是由甲状旁腺主细胞合成并分泌的多肽类分子,是维持机体钙磷代谢平衡的一种重要的调钙激素,可促进骨形成与骨吸收,加快骨转换。目前临床上甲状旁腺激素主要用于防治妇女绝经期骨质疏松症和降低骨折的发生率。甲状旁腺激素通过刺激成骨细胞、破骨细胞、牙周膜细胞、成牙骨质细胞等的增殖和分化来促进牙周组织改建和愈合,有效地控制牙槽骨的丧失,加速正畸牙的移动,以及促进种植体与牙槽骨的骨结合。本文就近年来甲状旁腺激素对牙周组织再生与改建的相关临床和基础研究作一综述,旨在为甲状旁腺激素在牙周组织的应用与研究提供参考。

关键词: 甲状旁腺激素, 牙周组织, 骨再生, 牙槽骨

Abstract: Parathyroid hormone(PTH) is a polypeptide molecule synthesized and secreted by the chief cell of parathyroid glands and is a vital calcium-regulating hormone, which could maintain the balance of calcium and phosphorus metabolism in vivo. PTH could promote the regeneration and absorption of bone and accelerate bone turnover. Nowadays, PTH is used for the prevention and treatment of osteoporosis in menstruating women and could decrease the rate of fracture in clinic. Moreover, researchers found that PTH could promote the concrescence and remodeling of periodontal tissue, control the absorption of alveolar bone, accelerate orthodontic tooth movement, and improve the osseointegration of dental implant by stimulating the proliferation and differentiation of osteoblast, osteoclast, periodontal ligament cell, and cementoblast. This review focuses on the progress of PTH in the regeneration and remodeling of periodontal tissue in recent years.

Key words: parathyroid hormone, periodontal tissue, bone regeneration, alveolar bone

中图分类号:

Q813

安宁, 唐正龙. 甲状旁腺激素调控牙周组织改建的研究进展[J]. 国际口腔医学杂志, 2017, 44(4): 466-470.

An Ning, Tang Zhenglong. Research progress on the regulation of parathyroid hormone on the remodeling of periodontal tissues[J]. Inter J Stomatol, 2017, 44(4): 466-470.

参考文献

[1] Mansjur KQ, Kuroda S, Izawa T, et al. The effec-tiveness of human parathyroid hormone and low-intensity pulsed ultrasound on the fracture healing in osteoporotic bones[J]. Ann Biomed Eng, 2016, 44 (8):2480-2488.
[2] Aggarwal P, Zavras A. Parathyroid hormone and its effects on dental tissues[J]. Oral Dis, 2012, 18(1):48- 54.
[3] Tang ZL, Zhang WJ, Wang DX, et al. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injec-tion of parathyroid hormone[J]. J Oral Maxillofac Surg, 2014, 72(2):419-430.
[4] Tang ZL, Bai S, Zhu PN, et al. An examination of differences in the new bone formation promoted by different doses of recombinant human parathyroid hormone during mandibular distraction osteogenesis [J]. Plast Reconstr Surg, 2016, 137(2):347e-354e.
[5] Tanaka S, Hata K, Yoneda T. Potential use of parathyroid hormone(PTH) in the treatments for oral diseases[J]. Clin Calcium, 2012, 22(1):75-82.
[6] Vasconcelos DF, Vasconcelos AC. PTH intermittent administration may be a useful therapeutic agent to avoid premature eruption of the tooth[J]. Med Hypo-theses, 2016, 88:27-29.
[7] Almagro MI, Roman-Blas JA, Bellido M, et al. PTH [1-34] enhances bone response around Titanium implants in a rabbit model of osteoporosis[J]. Clin Oral Implants Res, 2013, 24(9):1027-1034.
[8] Tokunaga K, Seto H, Ohba H, et al. Topical and intermittent application of parathyroid hormone re-covers alveolar bone loss in rat experimental perio-dontitis[J]. J Periodontal Res, 2011, 46(6):655-662.
[9] Bashutski JD, Eber RM, Kinney JS, et al. Teri-paratide and osseous regeneration in the oral cavity [J]. N Engl J Med, 2010, 363(25):2396-2405.
[10] Barros SP, Silva MA, Somerman MJ, et al. Para-thyroid hormone protects against periodontitis-associated bone loss[J]. J Dent Res, 2003, 82(10): 791-795.
[11] Cheung A, Seeman E. Teriparatide therapy for alendronate-associated osteonecrosis of the jaw[J]. N Engl J Med, 2010, 363(25):2473-2474.
[12] Hata K. Clinical and preclinical application of PTH and BMP to dental treatment[J]. Clin Calcium, 2016, 26(3):466-474.
[13] Wang X, Wang Y, Dai X,et al. Effects of inter-mittent administration of parathyroid hormone(1-34) on bone differentiation in stromal precursor an-tigen-1 positive human periodontal ligament stem cells[J]. Stem Cells Int, 2016, 2016:4027542.
[14] Vasconcelos DF, Marques MR, Benatti BB, et al. Intermittent parathyroid hormone administration improves periodontal healing in rats[J]. J Periodon-tol, 2014, 85(5):721-728.
[15] Otawa M, Tanoue R, Kido H, et al. Intermittent administration of parathyroid hormone ameliorates periapical lesions in mice[J]. J Endod, 2015, 41(5): 646-651.
[16] Kuroshima S, Kovacic BL, Kozloff KM, et al. Intra-oral PTH administration promotes tooth extraction socket healing[J]. J Dent Res, 2013, 92(6):553-559.
[17] Beppu K, Kido H, Watazu A, et al. Peri-implant bone density in senile osteoporosis-changes from implant placement to osseointegration[J]. Clin Implant Dent Relat Res, 2013, 15(2):217-226.
[18] Marques MR, Da Silva MA, Manzi FR, et al. Effect of intermittent PTH administration in the perio-dontitis-associated bone loss in ovariectomized rats [J]. Arch Oral Biol, 2005, 50(4):421-429.
[19] Takedachi M, Murakami S. Present status of perio-dontal regeneration—FGF-2 and Teriparatide[J]. Clin Calcium, 2012, 22(1):99-104.
[20] Monnouchi S, Maeda H, Yuda A, et al. Mechanical induction of interleukin-11 regulates osteoblastic/cementoblastic differentiation of human periodontal ligament stem/progenitor cells[J]. J Periodontal Res, 2015, 50(2):231-239.
[21] Wolf M, Jäger A, Abuduwali N, et al. Continuous PTH modulates alkaline phosphatase activity in human PDL cells via protein kinase C dependent pathways in vitro [J]. Ann Anat, 2013, 195(5):455- 460.
[22] Wolf M, Lossdörfer S, Abuduwali N, et al. Effect of intermittent PTH(1-34) on human periodontal liga-ment cells transplanted into immunocompromised mice[J]. Tissue Eng Part A, 2012, 18(17/18):1849- 1856.
[23] Wolf M, Lossdörfer S, Abuduwali N, et al. Potential role of high mobility group box protein 1 and intermittent PTH(1-34) in periodontal tissue repair following orthodontic tooth movement in rats[J]. Clin Oral Investig, 2013, 17(3):989-997.
[24] Jin SH, Lee JE, Yun JH, et al. Isolation and charac-terization of human mesenchymal stem cells from gingival connective tissue[J]. J Periodontal Res, 2015, 50(4):461-467.
[25] Ren YJ, Maltha JC, Kuijpers-Jagtman AM. Optimum force magnitude for orthodontic tooth movement: a systematic literature review[J]. Angle Orthod, 2003, 73(1):86-92.
[26] Lossdörfer S, Yildiz F, Götz W, et al. Anabolic effect of intermittent PTH(1-34) on the local microenviron-ment during the late phase of periodontal repair in a rat model of tooth root resorption[J]. Clin Oral In-vestig, 2010, 14(1):89-98.
[27] Wang L, Tran AB, Nociti FH, et al. PTH and vitamin D repress DMP1 in cementoblasts[J]. J Dent Res, 2015, 94(10):1408-1416.
[28] Soma S, Iwamoto M, Higuchi Y, et al. Effects of continuous infusion of PTH on experimental tooth movement in rats[J]. J Bone Miner Res, 1999, 14(4): 546-554.
[29] Soma S, Matsumoto S, Higuchi Y, et al. Local and chronic application of PTH accelerates tooth move-ment in rats[J]. J Dent Res, 2000, 79(9):1717-1724.
[30] Salazar M, Hernandes L, Ramos AL, et al. Effect of teriparatide on induced tooth displacement in ovariec-tomized rats: a histomorphometric analysis[J]. Am J Orthod Dentofacial Orthop, 2011, 139(4):e337-e344.
[31] Li F, Li G, Hu H, et al. Effect of parathyroid hor-mone on experimental tooth movement in rats[J]. Am J Orthod Dentofacial Orthop, 2013, 144(4):523- 532.
[32] Stanford CM, Schneider GB. Functional behaviour of bone around dental implants[J]. Gerodontology, 2004, 21(2):71-77.
[33] Skripitz R, Johansson HR, Ulrich SD, et al. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats[J]. J Orthop Sci, 2009, 14(2):138-143.
[34] Bellido M, Lugo L, Castañeda S, et al. PTH in-creases jaw mineral density in a rabbit model of osteoporosis[J]. J Dent Res, 2010, 89(4):360-365.
[35] Heo HA, Park SH, Jeon YS, et al. Enhancing effect of intermittent parathyroid hormone administration on bone formation after Titanium implant placement in an ovariectomized rat maxilla[J]. Implant Dent, 2016, 25(2):227-231.
[36] Lima LL, César Neto JB, Cayana EG, et al. Para-thyroid hormone(1-34) compensates the negative effect of smoking around implants[J]. Clin Oral Im-plants Res, 2013, 24(9):1055-1059.
[37] Zeng X, He H, Zhang L, et al. A potential therapeutic approach to overload-induced bone loss around implant: parathyroid hormone(PTH)[J]. Med Hypo-theses, 2011, 77(5):701-704.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed